Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Efficacy of Injectable PRF in Management of TMJ Internal Derangement

NCT: NCT07789860 · COMPLETED

NCT IDNCT07789860
StatusCOMPLETED
Start Date2023-09-30
Completion2024-10-30
SponsorSuez Canal University (OTHER)
First posted
Last updated

Brief Summary

This study evaluated the efficacy of injectable platelet-rich fibrin both clinically and using MRI in management of temporomandibular joint internal derangement

Frequently Asked Questions

What is Efficacy of Injectable PRF in Management of TMJ Internal Derangement?

Efficacy of Injectable PRF in Management of TMJ Internal Derangement is a clinical trial registered under NCT07789860. Current status: COMPLETED.

What is the status of NCT07789860?

The current status of NCT07789860 (Efficacy of Injectable PRF in Management of TMJ Internal Derangement) is: COMPLETED.

When did Efficacy of Injectable PRF in Management of TMJ Internal Derangement start?

Efficacy of Injectable PRF in Management of TMJ Internal Derangement started on 2023-09-30.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑